A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses

NCT03362593 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

186

Enrollment

INDUSTRY

Sponsor class

Stopped The program is canceled due to company strategic reasons.

Conditions

Healthy Volunteers

Interventions

DRUG: MEDI7219
DRUG: Placebo
DRUG: Formulation without Active Drug

Sponsor

MedImmune LLC